BRUSSELS, July 8 (Reuters) – The European Commission said on Wednesday it would seek feedback on commitments offered by French pharmaceutical company Sanofi to address concerns that it may have breached competition rules in a flu vaccine marketing campaign.
The Commission opened an investigation two weeks ago into whether Sanofi had carried out a misleading campaign to sell its “Efluelda” flu vaccine while disparaging a rival one called “Fluad” made by CSL Seqirus, primarily in France and Germany.
To address the Commission concerns, Sanofi offered a series of commitments, such as publishing statements on its website, that would remain in force until 2030.
(Reporting by Inti Landauro; editing by Foo Yun Chee)
Comments